“Anti-cancer therapies often exhibit only short-term effects. Tumors typically develop drug resistance causing relapses that might be tackled with drug combinations. Identification of the right combination is challenging and would benefit from high-content, high-throughput combinatorial screens directly on patient biopsies. However, such screens require a large amount of material, normally not available from patients. To address these challenges, we present a scalable microfluidic workflow, called Combi-Seq, to screen hundreds of drug combinations in picoliter-size droplets using transcriptome changes as a readout for drug effects. We devise a deterministic combinatorial DNA barcoding approach to encode treatment conditions, enabling the gene expression-based readout of drug effects in a highly multiplexed fashion. We apply Combi-Seq to screen the effect of 420 drug combinations on the transcriptome of K562 cells using only ~250 single cell droplets per condition, to successfully predict synergistic and antagonistic drug pairs, as well as their pathway activities.”
Figures and the abstract are reproduced from Mathur, L., Szalai, B., Du, N.H. et al. Combi-seq for multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets. Nat Commun 13, 4450 (2022). https://doi.org/10.1038/s41467-022-32197-0
Read the original article: Combi-seq for multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets
In droplet microfluidics, high-throughput screening is critical for analyzing large cellular or molecular libraries at…
In the ever-evolving landscape of biochemical research, protein complexes characterization plays an important role in…
Understanding of a protein’s true behavior in biological systems remains a cornerstone for understanding biological…
Pancreatic cancer, notorious for its poor prognosis and rapid progression, remains a significant challenge in…
Understanding how microglia, the brain's immune cells, respond to inflammation is pivotal for grasping the…
Recent advancements in microfabrication of microfluidic chips are pushing the boundaries of nanoparticle design, offering…